Benitec appoints Sophie Mukadam as COO, Megan Boston as CFO; grants stock options to executives

Benitec Biopharma Inc.

Sophie Mukadam appointed COO effective Jan 1, 2025; base salary $500K, target bonus 40%.
Megan Boston confirmed as Secretary and CFO effective Jan 1, 2025; continues as principal financial/accounting officer.
CEO Jerel Banks granted options for 2.31M shares at $12.18, vesting quarterly over four years.
CFO Megan Boston granted options for 720K shares at same price/vesting schedule.
Base salaries increased: CEO to $667K, CFO to $415K, effective Jan 1, 2025; target bonuses 55% and 40%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.